NO20081704L - Et peptid-immunoglobulin-konjugat - Google Patents

Et peptid-immunoglobulin-konjugat

Info

Publication number
NO20081704L
NO20081704L NO20081704A NO20081704A NO20081704L NO 20081704 L NO20081704 L NO 20081704L NO 20081704 A NO20081704 A NO 20081704A NO 20081704 A NO20081704 A NO 20081704A NO 20081704 L NO20081704 L NO 20081704L
Authority
NO
Norway
Prior art keywords
peptide
immunoglobulin conjugate
peptide immunoglobulin
immunoglobulin
peptides
Prior art date
Application number
NO20081704A
Other languages
English (en)
Inventor
Erhard Kopetzki
Stephan Fischer
Ralf Schumacher
Suryanarayana Sankuratri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081704(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20081704L publication Critical patent/NO20081704L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse angår peptid-immunglobulin-konjugater hvor minst to av de terminale endene av immunglobulin polypeptidkjedene er konjugert til et peptid, hvorved peptidene kan være forskjellige, lignende eller identiske. Konjugeringen finner sted på nukleinsyrenivå.
NO20081704A 2005-10-21 2008-04-07 Et peptid-immunoglobulin-konjugat NO20081704L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023002 2005-10-21
PCT/EP2006/010061 WO2007045463A1 (en) 2005-10-21 2006-10-19 A peptide-immunoglobulin-conjugate

Publications (1)

Publication Number Publication Date
NO20081704L true NO20081704L (no) 2008-06-05

Family

ID=35809600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081704A NO20081704L (no) 2005-10-21 2008-04-07 Et peptid-immunoglobulin-konjugat

Country Status (13)

Country Link
US (1) US20070148180A1 (no)
EP (1) EP1940882A1 (no)
JP (1) JP2009512655A (no)
KR (1) KR20080070014A (no)
CN (1) CN101291956A (no)
AR (1) AR056137A1 (no)
AU (1) AU2006303438A1 (no)
BR (1) BRPI0617511A8 (no)
CA (1) CA2625332A1 (no)
IL (1) IL190552A0 (no)
NO (1) NO20081704L (no)
TW (1) TW200722436A (no)
WO (1) WO2007045463A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
US7820623B2 (en) 2006-10-25 2010-10-26 Amgen Inc. Conjugated toxin peptide therapeutic agents
JP5591691B2 (ja) 2007-05-22 2014-09-17 アムジエン・インコーポレーテツド 生物活性を有する融合タンパク質を作製するための組成物及び方法
ES2695999T3 (es) 2007-10-12 2019-01-11 Hoffmann La Roche Expresión de proteínas a partir de múltiples ácidos nucleicos
CA2755133A1 (en) 2009-03-20 2010-09-23 Amgen Inc. Selective and potent peptide inhibitors of kv1.3
TW201129379A (en) 2009-11-20 2011-09-01 Amgen Inc Anti-Orai1 antigen binding proteins and uses thereof
EP2603794A1 (en) 2010-08-10 2013-06-19 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
CN103339145A (zh) * 2010-09-22 2013-10-02 安姆根有限公司 运载体免疫球蛋白及其用途
CA2823707A1 (en) 2011-01-18 2012-07-26 Amgen Inc. Nav1.7 knockout mice and uses thereof
CA2858389A1 (en) * 2011-12-15 2013-06-20 The Royal Institution For The Advancement Of Learning/Mcgill University Soluble igf receptor fc fusion proteins and uses thereof
AU2013222188A1 (en) 2012-02-22 2014-09-11 Amgen Inc. Autologous mammalian models derived from induced pluripotent stem cells and related methods
EP3207146B1 (en) 2014-10-15 2021-09-29 Amgen Inc. Promoter and regulatory elements for improved expression of heterologous genes in host cells
EP3568411B1 (en) 2017-01-13 2024-03-06 Pietro P. Sanna Methods and compositions for treating hpa hyperactivity
WO2019066603A1 (ko) * 2017-09-29 2019-04-04 한미약품 주식회사 효력이 향상된 지속성 단백질 결합체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
ES2252732T3 (es) * 1992-05-26 2006-05-16 Immunex Corporation Nueva citoquina que une cd30.
US6620413B1 (en) * 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
NZ332566A (en) * 1996-05-22 2000-08-25 Novopharm Biotech Inc Antigen binding fragments that specifically detect cancer cells
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
JP2004509978A (ja) * 2000-06-05 2004-04-02 ユニバーシティ　オブ　テネシー　コーポレイション 免疫抑制因子のエンドサイトーシスによる提示のための組成物及び方法
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
RU2006128593A (ru) * 2004-01-07 2008-02-20 Тримерис, Инк. (Us) Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека

Also Published As

Publication number Publication date
CN101291956A (zh) 2008-10-22
KR20080070014A (ko) 2008-07-29
BRPI0617511A8 (pt) 2018-04-24
EP1940882A1 (en) 2008-07-09
CA2625332A1 (en) 2007-04-26
US20070148180A1 (en) 2007-06-28
BRPI0617511A2 (pt) 2015-07-07
AR056137A1 (es) 2007-09-19
JP2009512655A (ja) 2009-03-26
AU2006303438A1 (en) 2007-04-26
TW200722436A (en) 2007-06-16
WO2007045463A1 (en) 2007-04-26
IL190552A0 (en) 2008-11-03

Similar Documents

Publication Publication Date Title
NO20081704L (no) Et peptid-immunoglobulin-konjugat
CY1119943T1 (el) Πεγκυλιωμενα σακχαρα και γλυκοπεπτιδια διασυνδεδεμενα με γλυκερολη
EP2163562A3 (en) IL-1beta binding antibodies and fragments thereof
NZ611324A (en) Il-17 binding proteins
NZ625630A (en) Human il-23 antigen binding proteins
WO2008095004A3 (en) Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
NZ597168A (en) Dual variable domain immunoglobin and uses thereof
WO2007039231A3 (en) Method of producing a modified (poly)peptide
WO2008093058A3 (en) Peptides and their use
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2003074546A8 (de) Streptavidin-bindungspeptid
WO2007016303A3 (en) Unsaturated polyester resin compositions with improved weatherabilty
CY1115832T1 (el) Πεπτιδια που προερχονται απο fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων
EA200800109A1 (ru) Суправалентные соединения
EA200870137A1 (ru) Конъюгаты лекарство-полимер
WO2007110772A8 (en) Immunomodulating oligopeptides
MX2009009370A (es) Conjugados del complemento de peptido.
EP1691664A4 (en) ANTIBODIES AND / OR THEIR CONJUGATES BINDING TO THE AMINOTERMINAL FRAGMENT OF UROKINASE, COMPOSITIONS AND THEIR USES
WO2008069965A3 (en) Novel genes and proteins that home to developing microvessels
TH88615A (th) เปปไทด์-อิมมูโนโกลบูลิน-คอนจูเกต
TH88615B (th) เปปไทด์-อิมมูโนโกลบูลิน-คอนจูเกต
AU2021903144A0 (en) Antibody and peptide conjugates, therapeutic peptides and uses thereof
RU2008107183A (ru) Композиция, имеющая активность ингибитора ангиогенеза
AU2020903537A0 (en) Antibody and peptide conjugates, therapeutic peptides and uses thereof
RU2022114441A (ru) Модифицированная l-аспарагиназа

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application